Abstract
A rare form of putative natural killer (NK) cell lymphoma called blastic NK cell lymphoma appears to be clinicopathologically distinctive in showing a homogenous lymphoblast, variable expression of CD2, CD4, CD56 and TdT, negative for surface CD3, T-cell receptor antigen, CD16, CD34 and lack of association with Epstein-Barr virus (EBV). We report two patients with blastic NK cell lymphoma and describe the interesting clinical studies. The patients presented with cutaneous plaques. Both patients had adenopathy, and one had marrow involvement at presentation. Unlike in many NK and NK-like T-cell disorders, azurophilic cytoplasmic granules were absent. They expressed intermediate density CD45. In addition, the cells were positive for HLA-DR, CD2, CD4, CD56 and TdT, and negative for EBV transcripts. In spite of the advanced clinical stage, complete remission was achieved by conventional chemotherapy. After interleukin 2 expansion of tumour-infiltrating bone marrow and lymph node cells from the patients, cytotoxic T-cell lines with rearranged T-cell receptor genes were established. They showed specific killing activity against autologous tumour cells in an MHC-restricted fashion, with possible implications for treatment. In addition...Continue Reading
References
Mar 1, 1992·American Journal of Hematology·T MotojiH Mizoguchi
Jul 1, 1991·British Journal of Haematology·J M BennettC Sultan
Jan 1, 1991·Annual Review of Immunology·E R PodackM G Lichtenheld
Jan 1, 1990·Leukemia Research·M SarfatiG Biron
Jan 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D E SlaterZ Arlin
Aug 3, 1984·Journal of Immunological Methods·H YsselH Spits
Apr 1, 1981·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·S M HsuH Fanger
Jul 22, 1994·Science·D KägiP Golstein
Mar 1, 1995·The American Journal of Surgical Pathology·S NakamuraE Katoh
Jul 1, 1994·The Journal of Experimental Medicine·A N Houghton
Mar 20, 1993·Annals of the New York Academy of Sciences·G T StelzerM R Loken
Jan 1, 1996·The American Journal of Surgical Pathology·E S JaffeF C Ho
Jun 15, 1996·Cancer·R IchinohasamaT Sawai
Jun 1, 1996·Immunity·A ShibuyaJ H Phillips
Mar 1, 1996·Fungal Genetics and Biology : FG & B
Feb 1, 1996·Histopathology·Y KobashiT Suchi
May 1, 1997·British Journal of Haematology·O YamadaK Oshimi
Oct 23, 1997·The American Journal of Surgical Pathology·J A DiGiuseppeM J Borowitz
Jul 10, 1999·Leukemia Research·R Suzuki, S Nakamura
Citations
Nov 7, 2007·Journal of Pediatric Hematology/oncology·Ann Veronique C EguarasMa Luz U Del Rosario
Apr 12, 2003·Leukemia & Lymphoma·Soo-Zin KimEckhart Weidmann
Apr 11, 2003·Leukemia & Lymphoma·Filiz VuralBulent Undar
Jan 21, 2012·Leukemia & Lymphoma·Lila GilisAnne-Sophie Michallet
Jun 25, 2010·Pathology, Research and Practice·Yang LiBin Li
Apr 19, 2007·American Journal of Clinical Pathology·Marco Herling, Dan Jones
Jan 2, 2007·Cancer Letters·Amit W Panwalkar, James O Armitage
Feb 6, 2010·The British Journal of Dermatology·J GurgenW Sexton
Sep 2, 2003·American Journal of Hematology·Michael ShapiroStephen J Schuster
Sep 18, 2003·Bone Marrow Transplantation·P ReimerM Wilhelm
Apr 16, 2005·Journal of Korean Medical Science·Yoonjung KimYoung H Ko
Jul 7, 2005·Cancer·Ritsuro SuzukiUNKNOWN NK-cell Tumor Study Group
Sep 27, 2005·American Journal of Hematology·Masaki YamaguchiMikio Ueda
Nov 20, 2013·The American Journal of Dermatopathology·Shweta GeraJeong Hee Cho-Vega
Apr 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kiyotaka KawauchiOsamu Yamada